Advertisement
Australia markets open in 2 hours 18 minutes
  • ALL ORDS

    8,034.90
    -23.70 (-0.29%)
     
  • AUD/USD

    0.6651
    -0.0007 (-0.11%)
     
  • ASX 200

    7,766.70
    -21.60 (-0.28%)
     
  • OIL

    80.28
    +2.56 (+3.29%)
     
  • GOLD

    2,362.40
    +27.90 (+1.20%)
     
  • Bitcoin AUD

    102,758.08
    -1,930.23 (-1.84%)
     
  • CMC Crypto 200

    1,477.06
    -19.40 (-1.30%)
     

Verastem Oncology to Present at the RBC Capital Markets Global Healthcare Conference

BOSTON, May 07, 2024--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 14, 2024 at 3:35 pm EDT.

A live webcast of the fireside chat can be accessed under events on the Verastem Oncology’s website at www.verastem.com. A replay of the webcast will be archived on the website for approximately 90 days following the presentation.

About Verastem Oncology

Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on RAS/MAPK-driven cancers, specifically novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and FAK inhibition. For more information, please visit www.verastem.com and follow us on LinkedIn.

ADVERTISEMENT

View source version on businesswire.com: https://www.businesswire.com/news/home/20240507625461/en/

Contacts

For Investor and Media Inquiries:
Julissa Viana
Vice President, Corporate Communications and Investor Relations
investors@verastem.com or
media@verastem.com